This content is machine translated Diabetes Targeted therapy in the metabolic patient Nearly 4200 attendees registered at the DDG Fall Meeting 2021which was held under the motto “Diabetes and obesity – together through thick and thin” – was a complete success. The…
View Post 15 min This content is machine translated Therapy of venous occlusions Endovascular interventions – option for patients with more pronounced symptoms Deep vein thrombosis develops in 1/1000 inhabitants of Western Europe per year. In the acute phase, it is critical to prevent the complication of pulmonary artery embolism. This is now… CME-Test
View Post 3 min This content is machine translated Hypertension Uncontrolled hypertension in the elderly: dose increase or another drug? If the target blood pressure is not achieved, there are two approaches to intensify antihypertensive treatment: adding a new drug or maximizing the dose. A large-scale cohort study involving researchers from…
View Post 3 min This content is machine translated Dyslipidemia Effective lipid management – lipid apheresis as a last resort? Current European guidelines advocate strict LDL-C lowering to prevent cardiovascular disease. Statins, which can significantly lower both total and LDL cholesterol, play a central role. In addition, PCSK9 inhibitors achieve…
View Post 13 min This content is machine translated Kidney diseases What to do in case of chronic creatinine increase? The proportion of patients with CKD increases sharply with age. The most common causes are diabetes mellitus and arterial hypertension. Early onset of secondary complications can significantly affect the prognosis.… CME-Test
View Post 3 min This content is machine translated High-risk cardiology patients Facts and Figures on Antithrombotic Therapy Anticoagulation is associated with many challenges – even more so when patients belong to a high-risk group. This is because the combination of different preparations can be associated with risks,…
View Post 8 min This content is machine translated Arterial hypertension Treatment in elderly and frail patients – a challenge Treatment of arterial hypertension in elderly and frail patients presents challenges at many levels. Because they tend to be at increased risk for adverse effects, medication should be started cautiously.… CME-Test
View Post 4 min This content is machine translated European Society of Cardiology Annual Congress 2021 Evolocumab provides additional benefit for maximal LDL-C reduction “The lower the better” is an important principle for lipid-lowering therapies, and PCSK9 monoclonal antibodies (PCSK9 mAb), such as evolocumab, can effectively lower LDL-C levels [1]. Data from the ECARA…
View Post 3 min This content is machine translated Primary hyperaldosteronism Therapy-resistant hypertension: clarify for Conn syndrome! If high blood pressure cannot be adequately controlled despite antihypertensive drugs, this may be due to undetected hormonal causes. Hypertension due to primary hyperaldosteronism, also known as “Conn syndrome,” is…
View Post 5 min This content is machine translated The metabolic patient Type 2 diabetes: reducing cardiovascular risk through lipid lowering Diabetes is associated with increased cardiovascular risk. Multifactorial therapy of the four major risk factors of blood glucose, weight, hypertension, and dyslipidemia in individuals with type 2 diabetes is challenging.…
View Post 6 min This content is machine translated Despite Corona emergency Do not ignore warning signals from the heart With the current dramatic rise in SARS-CoV-2 infections and the associated emergency in hospitals and intensive care units, heart specialists fear that cardiac patients with acute heart conditions may once…
